Atlantic International (ATLN)
NASDAQ:ATLN
Top Page
Atlantic International
(NASDAQ:ATLN)
Select Model
Select Model
Rating:54Neutral
Price Target:
$3.50
▼(-21.35% Downside)
Action:ReiteratedDate:02/04/26
The score is held back primarily by weak financial health—loss-making operations and a highly concerning balance sheet with negative equity—despite strong revenue growth. Technicals are supportive with strong upward momentum above major moving averages, and corporate events are positive (acquisition and new CFO), but valuation is constrained by negative earnings and no stated dividend yield.
Positive Factors
Acquisition-driven Global Scale
The all-stock acquisition of Circle8 creates a combined ~ $1.2B unaudited revenue platform and broadens geographic reach into Europe. This materially diversifies revenue and client coverage, enabling scale economics, cross-selling and structural revenue stability over the medium term.
Negative Factors
Negative Profitability / Low Margins
Persistent negative profitability and a low gross margin (~10.85%) signal weak pricing power or high input costs across core businesses. Continued margins pressure limits internal reinvestment, lengthens payback on acquisitions and complicates the path to sustainable operating profitability over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Acquisition-driven Global Scale
The all-stock acquisition of Circle8 creates a combined ~ $1.2B unaudited revenue platform and broadens geographic reach into Europe. This materially diversifies revenue and client coverage, enabling scale economics, cross-selling and structural revenue stability over the medium term.
Read all positive factors
Atlantic International (ATLN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$216.01M
Dividend YieldN/A
Average Volume (3M)364.23K
Price to Earnings (P/E)―
Beta (1Y)0.07
Revenue Growth109.65%
EPS Growth77.14%
CountryUS
Employees300
SectorIndustrials
Sector Strength72
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)-0.20
Shares Outstanding62,611,656
10 Day Avg. Volume70,257
30 Day Avg. Volume364,234
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-14.94
Price to Sales (P/S)0.41
P/FCF Ratio-29.63
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue0.72
Enterprise Value/Gross Profit6.65
Enterprise Value/Ebitda-5.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.61
Revenue Forecast (FY)$481.08M
Atlantic International Business Overview & Revenue Model
Company Description
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on devel...
How the Company Makes Money
Atlantic International generates revenue through multiple streams. Primarily, the company earns income from its telecommunications segment by offering mobile and internet services to consumers and businesses, charging subscription fees and usage-b...
Atlantic International Financial Statement Overview
Summary
Income Statement
30
Negative
Balance Sheet
20
Very Negative
Cash Flow
35
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 445.38M | 442.61M | 401.37M | 441.54M | 425.03M | 329.50K |
| Gross Profit | 48.34M | 47.18M | 46.88M | 54.21M | 54.41M | 158.69K |
| EBITDA | -63.08M | -113.10M | 1.44M | 11.94M | 12.18M | -649.39K |
| Net Income | -100.93M | -135.48M | -15.25M | -3.22M | -40.80M | -1.05M |
Balance Sheet | ||||||
| Total Assets | 110.26M | 122.75M | 126.67M | 8.41M | 10.74M | 694.04K |
| Cash, Cash Equivalents and Short-Term Investments | 83.41K | 678.68K | 1.35M | 6.22M | 9.95M | 0.00 |
| Total Debt | 76.66M | 82.72M | 142.62M | 2.93M | 1.38M | 3.56M |
| Total Liabilities | 132.32M | 134.77M | 166.02M | 4.05M | 2.56M | 4.55M |
| Stockholders Equity | -22.06M | -12.02M | -39.35M | 4.37M | 8.18M | -3.85M |
Cash Flow | ||||||
| Free Cash Flow | 3.29M | -6.06M | -9.16M | -3.70M | -2.00M | -757.91K |
| Operating Cash Flow | 3.36M | -5.99M | -9.08M | -3.66M | -1.99M | -757.91K |
| Investing Cash Flow | -67.58K | -73.46K | -73.71K | 1.83M | -5.99M | 0.00 |
| Financing Cash Flow | -4.60M | 5.38M | 8.79M | 0.00 | 12.00M | 752.05K |
Atlantic International Technical Analysis
Neutral
4.45
Price Trends
3.31
Positive
2.66
Positive
2.77
Positive
Market Momentum
0.27
Positive
47.50
Neutral
48.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATLN, the sentiment is Neutral. The current price of 4.45 is above the 20-day moving average (MA) of 3.58, above the 50-day MA of 3.31, and above the 200-day MA of 2.77, indicating a neutral trend. The MACD of 0.27 indicates Positive momentum. The RSI at 47.50 is Neutral, neither overbought nor oversold. The STOCH value of 48.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ATLN.
Atlantic International Risk Analysis
Atlantic International disclosed 48 risk factors in its most recent earnings report. Atlantic International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Atlantic International Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $361.14M | ― | -36.02% | ― | 159.45% | 8.59% | |
54 Neutral | $216.01M | -3.84 | ― | ― | 109.65% | 77.14% | |
52 Neutral | $431.73M | -4.66 | -52.04% | ― | -41.87% | -165.76% | |
47 Neutral | $110.84M | -2.33 | -138.87% | ― | 78.62% | 32.39% | |
44 Neutral | $68.55M | -6.57 | -126.62% | ― | 14.08% | 1.34% | |
43 Neutral | $157.90M | -5.33 | 516.59% | ― | 21.68% | 58.30% |
* Industrials Sector Average
ATLN
Atlantic International
3.45
-1.31
-27.52%
ACRS
Aclaris Therapeutics
3.30
1.63
97.60%
MDXH
MDxHealth
2.90
1.33
84.71%
STIM
Neuronetics
1.46
-2.92
-66.70%
XGN
Exagen
2.74
-1.12
-29.02%
PRE
Prenetics Group
22.15
18.11
448.27%
Atlantic International Corporate Events
Business Operations and StrategyExecutive/Board Changes
Atlantic International Appoints Kevin Murphy as New CFO
Positive
Feb 3, 2026
On January 12, 2026, Atlantic International Corp. appointed veteran finance executive Kevin J. Murphy, a certified public accountant with more than 27 years of experience in financial operations, reporting, and strategic transformation across staf...
Business Operations and StrategyExecutive/Board ChangesM&A Transactions
Atlantic International completes Circle8 acquisition, expanding globally
Positive
Jan 28, 2026
On January 23, 2026, Atlantic International Corp. completed its all-stock acquisition of Circle8 Group, a Netherlands-based IT and technology staffing specialist that operates across Europe and generated approximately $780 million in unaudited rev...
Executive/Board ChangesShareholder Meetings
Atlantic International Approves Key Proposals at AGM
Neutral
Nov 10, 2025
On November 7, 2025, Atlantic International held its Annual General Meeting, where 44.14% of the total outstanding shares were represented, surpassing the one-third quorum requirement. All proposals were approved, including the election of directo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.